Drug intelligence / Profile preview

CAR-504

Development stage: Preclinical
Lead developer: Carmel Biosciences
Modality: Small Molecules

Overview

CAR-504 is an investigational drug candidate being developed by Carmel Biosciences. According to the company's pipeline, the drug has received FDA Pre-IND approval and is currently in the IND-enabling stage of development. Carmel Biosciences specializes in developing novel formulations of established therapeutic agents, often focusing on cardiovascular and metabolic conditions, although the specific active ingredient and therapeutic target for CAR-504 have not been publicly disclosed as of early 2024.

Beyond the preview

Go deeper on CAR-504.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CAR-504.

Explore the full profile